Incidence of Dementia Among Participants and Nonparticipants in a Longitudinal Study of Cognitive Aging
Year: 2014
Type: article
Study design: Observational Study
Abstract: Although rates of incident dementia have been reported from several populations, the impact of nonparticipation on dementia incidence in studies of cognitive aging is unknown. In 2004, investigators with the Mayo Clinic Study of Aging selected persons aged 70-89 years from an enumeration of all Olmsted County, Minnesota, residents (age- and sex-stratified random sample). Of 4,398 potential participants, 2,050 agreed to undergo an in-person health assessment. Those participants were reevaluated in person using standard diagnostic procedures approximately every 15 months over a median follow-up period of 5.7 years (through September 15, 2013). There were 1,679 persons who refused any participation. A trained nurse abstractor reviewed the medical records of nonparticipants using the Rochester Epidemiology Project's medical record linkage system a median of 3.9 years after refusal. Nonparticipants had a higher prevalence of dementia than participants evaluated in person (6.5% vs. 3.3%; P < 0.0001). The standardized incidence of dementia was not significantly higher among the nonparticipants (23.2 per 1,000 person-years) than in those evaluated in person (19.6 per 1,000 person-years; hazard ratio = 1.17, 95% confidence interval: 0.95, 1.43 (P = 0.13); adjusted for education and sex, with age as the time scale). The small, nonsignificant impact of nonparticipation on rates of incident dementia is reassuring for future studies based on incident dementia cases.
Source: American Journal of Epidemiology
DOI: 10.1093/aje/kwu103
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Robert Wood Johnson Foundation, Mayo Clinic, Amgen, Eli Lilly and Company, Pfizer, Baxter International, Purdue University, Walter S. and Lucienne Driskill Foundation, Washington University in St. Louis, Takeda Pharmaceuticals U.S.A., Purdue Pharma, TauRx Pharmaceuticals, University of Cambridge, University of Oxford, H. Lundbeck A/S, National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Center for Research Resources, Janssen Biotech
Awards: Multimorbidity and Aging: Rochester Epidemiology Project, G3726924859, Alzheimers Disease Patient Registry, Psychiatric Characterization/Mild Cognitive Impairment, Vascular and Inflammatory Predictors of MCI Risk and Progression, Mayo Clinic Center for Translational Science Activities, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W2101240866
